Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01479894 · ClinicalTrials.gov registry record

Genetic Analysis to Evaluate the Racial Difference in the Outcome of Patients With Colon Cancer

A clinical trial, sponsored by University of Arkansas.

Completed
Registry status
44
Enrollment target

NCT01479894 is a clinical trial that has completed, run by University of Arkansas. The registered enrollment target is 44 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01479894 has completed, sponsored by University of Arkansas.

COMPLETED
Registry status
44 participants
Enrollment target

Study Summary

This is a retrospective genetic analysis of stored tumor tissue samples to evaluate the distribution of Recurrence Score® and gene groups of stage II colon cancer in African American (AA) and Caucasian individuals. Other covariant factors in the medical chart will be analyzed as well. Three institutions will contribute patients to this study with a total patient number goal of approximately 200 with approximately 100 being AA and approximately 100 being Caucasian. As enrollment in this study proceeds a Caucasian subject will be matched for every African American enrolled.

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2011-11
Est. Completion 2015-01

Sponsor

University of Arkansas

318 total trials

What the Registry Record Tells You About NCT01479894

The ClinicalTrials.gov registry entry for NCT01479894 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01479894 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01479894 about?

NCT01479894 is a clinical study titled "Genetic Analysis to Evaluate the Racial Difference in the Outcome of Patients With Colon Cancer". This is a retrospective genetic analysis of stored tumor tissue samples to evaluate the distribution of Recurrence Score® and gene groups of stage II colon cancer in African American (AA) and Caucasian individuals. Other covariant factors in the medical chart will be analyzed as well. Three institut...

What is the current status of trial NCT01479894?

This trial is currently completed. The enrollment target is 44 participants. The study started on 2011-11. Estimated completion is 2015-01.

Who is sponsoring clinical trial NCT01479894?

This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.